FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229016895> ?p ?o ?g. }

• W4229016895 endingPage "354" @default.
• W4229016895 startingPage "345" @default.
• W4229016895 abstract "Lactoferrin (LF) is a member of the transferrin family, which is known for its immunomodulatory properties. LF has been widely used as an anticancer medication in various cancers including breast cancer.The current study aimed to examine the molecular mechanisms underlying the therapeutic potential of recombinant human lactoferrin (rhLF), either alone or combined with epirubicin (EPI), in mice bearing solid Ehrlich carcinoma (SEC).SEC-bearing female mice (n=40) were divided into 4 equal groups. Mice were given rhLF orally (100mg/kg/mouse) daily and/or EPI i.p (8mg/kg/mouse). The experiment lasted 14 days, after which samples were collected to measure IL-18 and phosphorylated c-Jun N-terminal kinase (p-JNK) by ELISA and p53 gene expression by real-time PCR.Administration of rhLF, either alone or combined with EPI, markedly decreased the tumor volume and increased tumor inhibition rate as well as survival rate compared to either tumor control group or EPI-mono treated group. In addition, co-administration of rhLF and EPI increased the level of activated JNKs and expression of p53 in tumor tissues compared to the tumor, control group, exhibiting their pro-apoptotic properties. Moreover, the combined treatment with rhLF and EPI elevated IL-18 level in the intestinal mucosa compared to other experimental groups with a possible immune-enhancing effect.Recombinant human lactoferrin exhibited potential anticancer and immune-enhancing properties in mice with breast cancer. Co-treatment with rhLF and EPI proved to be a promising strategy in cancer treatment." @default.
• W4229016895 created "2022-05-08" @default.
• W4229016895 creator A5000262767 @default.
• W4229016895 creator A5007382115 @default.
• W4229016895 creator A5033628163 @default.
• W4229016895 creator A5079629865 @default.
• W4229016895 date "2023-08-01" @default.
• W4229016895 modified "2023-09-27" @default.
• W4229016895 title "Recombinant Human Lactoferrin Augments Epirubicin Chemotherapy in Solid Ehrlich Carcinoma Bearing Mice" @default.
• W4229016895 cites W1518480265 @default.
• W4229016895 cites W1981193495 @default.
• W4229016895 cites W2004427787 @default.
• W4229016895 cites W2006208579 @default.
• W4229016895 cites W2022361916 @default.
• W4229016895 cites W2023560061 @default.
• W4229016895 cites W2033262277 @default.
• W4229016895 cites W2038989792 @default.
• W4229016895 cites W2042756236 @default.
• W4229016895 cites W2046862942 @default.
• W4229016895 cites W2061561059 @default.
• W4229016895 cites W2064300632 @default.
• W4229016895 cites W2068303903 @default.
• W4229016895 cites W2079116952 @default.
• W4229016895 cites W2088542277 @default.
• W4229016895 cites W2097657129 @default.
• W4229016895 cites W2125304966 @default.
• W4229016895 cites W2132964444 @default.
• W4229016895 cites W2288903023 @default.
• W4229016895 cites W2334351103 @default.
• W4229016895 cites W2518238440 @default.
• W4229016895 cites W2589786476 @default.
• W4229016895 cites W2751615548 @default.
• W4229016895 cites W2766877925 @default.
• W4229016895 cites W2770686414 @default.
• W4229016895 cites W2776700091 @default.
• W4229016895 cites W2781999461 @default.
• W4229016895 cites W2792174894 @default.
• W4229016895 cites W2850674614 @default.
• W4229016895 cites W2926211323 @default.
• W4229016895 cites W2969775100 @default.
• W4229016895 cites W2994706659 @default.
• W4229016895 cites W3010658987 @default.
• W4229016895 cites W3017930579 @default.
• W4229016895 cites W3023105939 @default.
• W4229016895 cites W3046894702 @default.
• W4229016895 cites W3047498895 @default.
• W4229016895 cites W4246395405 @default.
• W4229016895 cites W822532126 @default.
• W4229016895 doi "https://doi.org/10.2174/1574886317666220429102445" @default.
• W4229016895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35507797" @default.
• W4229016895 hasPublicationYear "2023" @default.
• W4229016895 type Work @default.
• W4229016895 citedByCount "0" @default.
• W4229016895 crossrefType "journal-article" @default.
• W4229016895 hasAuthorship W4229016895A5000262767 @default.
• W4229016895 hasAuthorship W4229016895A5007382115 @default.
• W4229016895 hasAuthorship W4229016895A5033628163 @default.
• W4229016895 hasAuthorship W4229016895A5079629865 @default.
• W4229016895 hasConcept C104317684 @default.
• W4229016895 hasConcept C121608353 @default.
• W4229016895 hasConcept C126322002 @default.
• W4229016895 hasConcept C190283241 @default.
• W4229016895 hasConcept C203014093 @default.
• W4229016895 hasConcept C2777056448 @default.
• W4229016895 hasConcept C2779170986 @default.
• W4229016895 hasConcept C2780835546 @default.
• W4229016895 hasConcept C40767141 @default.
• W4229016895 hasConcept C502942594 @default.
• W4229016895 hasConcept C530470458 @default.
• W4229016895 hasConcept C55493867 @default.
• W4229016895 hasConcept C71924100 @default.
• W4229016895 hasConcept C86803240 @default.
• W4229016895 hasConcept C8891405 @default.
• W4229016895 hasConcept C98274493 @default.
• W4229016895 hasConceptScore W4229016895C104317684 @default.
• W4229016895 hasConceptScore W4229016895C121608353 @default.
• W4229016895 hasConceptScore W4229016895C126322002 @default.
• W4229016895 hasConceptScore W4229016895C190283241 @default.
• W4229016895 hasConceptScore W4229016895C203014093 @default.
• W4229016895 hasConceptScore W4229016895C2777056448 @default.
• W4229016895 hasConceptScore W4229016895C2779170986 @default.
• W4229016895 hasConceptScore W4229016895C2780835546 @default.
• W4229016895 hasConceptScore W4229016895C40767141 @default.
• W4229016895 hasConceptScore W4229016895C502942594 @default.
• W4229016895 hasConceptScore W4229016895C530470458 @default.
• W4229016895 hasConceptScore W4229016895C55493867 @default.
• W4229016895 hasConceptScore W4229016895C71924100 @default.
• W4229016895 hasConceptScore W4229016895C86803240 @default.
• W4229016895 hasConceptScore W4229016895C8891405 @default.
• W4229016895 hasConceptScore W4229016895C98274493 @default.
• W4229016895 hasIssue "3" @default.
• W4229016895 hasLocation W42290168951 @default.
• W4229016895 hasLocation W42290168952 @default.
• W4229016895 hasOpenAccess W4229016895 @default.
• W4229016895 hasPrimaryLocation W42290168951 @default.
• W4229016895 hasRelatedWork W2013577830 @default.
• W4229016895 hasRelatedWork W2022485647 @default.
• W4229016895 hasRelatedWork W2053374758 @default.

• next